| Nabil Hilwa, MD | |
|
7301 Stonerock Cir, Orlando, FL 32819-8004 | |
| (407) 298-6950 | |
| (407) 578-2354 |
| Full Name | Nabil Hilwa |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Location | 7301 Stonerock Cir, Orlando, Florida |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023041332 | NPI | - | NPPES |
| ME32104 | Other | FL | MEDICAL LICENSE |
| 059930100 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | ME32104 (Florida) | Primary |
| Entity Name | Orlando Health Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669429577 PECOS PAC ID: 9537059084 Enrollment ID: O20040318000044 |
News Archive
More rheumatologists are embracing musculoskeletal ultrasound (MSUS) to diagnose and manage rheumatic diseases. In response, the American College of Rheumatology (ACR) assembled a task force to investigate and determine best practices for use of MSUS in rheumatology practice. The resulting scenario-based recommendations, which aim to help clinicians understand when it is reasonable to integrate MSUS into their rheumatology practices, now appear online in Arthritis Care & Research.
A new study pinpoints certain aspects of the immune system that may play a role in the recurrence and progression of hepatitis C virus (HCV) after liver transplantation.
An article by Robert Belshe, M.D., of Saint Louis University School of Medicine in the New England Journal of Medicine reviews recent "spectacular achievements of contemporary molecular biology" that hold great importance as the world prepares for a possible flu pandemic.
Bioniche Life Sciences Inc. has provided an update on its Phase III clinical program evaluating Urocidin(TM) in the treatment of bladder cancer. On March 31st, the Company announced that recruitment had been completed in its initial Phase III registration trial evaluating Urocidin in the treatment of non-muscle-invasive bladder cancer that is refractory (unresponsive) to the current standard immunotherapy - Bacillus Calmette-Guérin (BCG).
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nabil Hilwa, MD 7301 Stonerock Cir, Orlando, FL 32819-8004 Ph: (407) 298-6950 | Nabil Hilwa, MD 7301 Stonerock Cir, Orlando, FL 32819-8004 Ph: (407) 298-6950 |
News Archive
More rheumatologists are embracing musculoskeletal ultrasound (MSUS) to diagnose and manage rheumatic diseases. In response, the American College of Rheumatology (ACR) assembled a task force to investigate and determine best practices for use of MSUS in rheumatology practice. The resulting scenario-based recommendations, which aim to help clinicians understand when it is reasonable to integrate MSUS into their rheumatology practices, now appear online in Arthritis Care & Research.
A new study pinpoints certain aspects of the immune system that may play a role in the recurrence and progression of hepatitis C virus (HCV) after liver transplantation.
An article by Robert Belshe, M.D., of Saint Louis University School of Medicine in the New England Journal of Medicine reviews recent "spectacular achievements of contemporary molecular biology" that hold great importance as the world prepares for a possible flu pandemic.
Bioniche Life Sciences Inc. has provided an update on its Phase III clinical program evaluating Urocidin(TM) in the treatment of bladder cancer. On March 31st, the Company announced that recruitment had been completed in its initial Phase III registration trial evaluating Urocidin in the treatment of non-muscle-invasive bladder cancer that is refractory (unresponsive) to the current standard immunotherapy - Bacillus Calmette-Guérin (BCG).
› Verified 9 days ago
Robert Anthony Badalament, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 601 E Rollins St, Orlando, FL 32803 Phone: 407-897-3499 Fax: 407-896-9454 | |
Dr. George Frederick Ellis, MD Urology Medicare: Medicare Enrolled Practice Location: 89 W Copeland Dr, Orlando, FL 32806 Phone: 321-842-6910 Fax: 321-843-5998 | |
Albert Michael Ong, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 41 W Kaley St, Orlando, FL 32806 Phone: 407-843-6645 Fax: 407-843-4519 | |
Jason Cheng-en Sea, MD, FRCSC Urology Medicare: Accepting Medicare Assignments Practice Location: 2101 Park Center Dr Ste 130, Orlando, FL 32835 Phone: 407-298-6950 Fax: 407-578-2354 | |
Joshua Adam Earl, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1812 N Mills Ave, Orlando, FL 32803 Phone: 407-897-3499 Fax: 407-896-9454 | |
Dr. Lucas Ross Wiegand, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 303 E Par St, Orlando, FL 32804 Phone: 877-876-3627 Fax: 321-843-4101 |